About
Sustained delivery of peptides
Areas of Focus
Categories
Drug Delivery & FormulationBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
59
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06988670Lead Sponsor
A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
PHASE2Recruiting
35 participants
Started: May 5, 2025 · Completed: May 31, 2027
NCT05408663Lead Sponsor
A Phase 1 Study of EXT608 in Healthy Adults
PHASE1Completed
24 participants
Started: Jul 21, 2022 · Completed: Jun 13, 2023
Locations (1)
Headquarters
Newton, MA, United States
Map
Loading map...